Related Experiment Video
Updated: May 10, 2025
08:08
Quantitative Mass Spectrometric Profiling of Cancer-cell Proteomes Derived From Liquid and Solid Tumors
Published on: February 27, 2015
16.0K
Quantitative proteomics analysis of triple-negative breast cancers
Natasha C Mariano1, Jonathan D Marotti2,3, Youdinghuan Chen4
1Department of Biochemistry and Cell Biology, Hanover, NH, USA.
NPJ Precision Oncology
|April 24, 2025
Summary
This study identifies four distinct subtypes of triple-negative breast cancer (TNBC) using proteomic analysis. These subtypes show unique molecular drivers and clinical features, offering new avenues for targeted breast cancer therapies.
Area of Science:
- Oncology
- Proteomics
- Genomics
Background:
- Triple-negative breast cancer (TNBC) represents a significant subset of breast cancer with aggressive behavior and limited treatment options.
- Tumor heterogeneity and a lack of specific oncogenic drivers contribute to TNBC's poor prognosis.
- There is a critical need for novel therapeutic strategies targeting TNBC.
Purpose of the Study:
- To classify triple-negative breast cancer subtypes using a proteomic approach.
- To associate proteomic profiles with distinct clinicopathological features and tumor microenvironment compositions.
- To identify potential therapeutic vulnerabilities and in vitro models for each TNBC subtype.
Main Methods:
- Quantitative proteomic analysis of 6306 proteins in 55 formalin-fixed, paraffin-embedded (FFPE) TNBC tumors.
- Unsupervised clustering of protein abundance data to define TNBC subtypes.
- Validation using genome-wide DNA methylation profiles to infer immune and stromal cell composition.
- Proteomic analysis of TNBC cell lines to establish subtype-specific in vitro models.
Main Results:
- Four distinct TNBC subtypes were identified based on proteomic profiles.
- Significant associations were found between proteomic subtypes and clinicopathological characteristics.
- Proteomic subtypes correlated with inferred immune and stromal cell compositions.
- TNBC cell lines were characterized to represent each identified subtype.
Conclusions:
- The proteomic classification reveals subtype-specific molecular drivers and phenotypes in TNBC.
- Understanding these subtypes provides insights into tumor microenvironment composition and potential therapeutic targets.
- This research offers a foundation for developing subtype-specific treatment strategies and improved in vitro models for TNBC research.
